| Financial Year |
March 31 2023 |
| Monetary Funds |
1,870,925,320.34 |
| Held-for-trading Financial Assets |
2,042,747,331.81 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,180,508,983.51 |
| Advances to Suppliers |
150,517,388.30 |
| Other Receivables |
64,204,651.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,070,694,119.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
343,071,957.59 |
| Total Current Assets |
6,722,669,752.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
421,290,680.73 |
| Investment Properties |
-- |
| Fixed Assetes |
842,633,381.07 |
| Under-construction Projects |
27,179,128.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
786,401,965.51 |
| R&D expenses |
9,784,154.83 |
| Goodwill |
1,965,142,892.57 |
| Long-Term Deferred and Prepaid Expenses |
36,196,203.66 |
| Deferred Income Tax Assets |
197,527,175.39 |
| Other Non-Current Assets |
533,658,791.29 |
| Sub-Total of Non-Current Assets |
5,851,015,406.85 |
| Total Assets |
12,573,685,159.00 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
967,279,287.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
190,714,403.08 |
| Taxes Payable |
245,298,345.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,837,470,607.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
478,376,925.01 |
| Other Current Liabilities |
70,089,611.17 |
| Sub-Total of Current Liabilities |
3,887,793,699.60 |
| Long-term Loans |
476,711,200.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
114,818,183.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,198,825,813.09 |
| Total Liabilities |
5,086,619,512.69 |
| Paid-In Capital(Or Share Stock) |
678,873,194.00 |
| Capital Surplus |
1,074,975,066.60 |
| Surplus Reserve |
392,410,127.08 |
| LESS:Treasury Stock |
162,209,884.65 |
| Undistributed Profits |
5,599,430,536.83 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,487,065,646.31 |
| Owner's Equity（Stockholder's Equity） |
7,487,065,646.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,573,685,159.00 |
